<DOC>
	<DOCNO>NCT02003703</DOCNO>
	<brief_summary>Hepatitis B virus infection common occurrence among patient HIV . Effective vaccine available , 's uncertainty regard specific dosage , specially among responded initial vaccination . The purpose study determine effectiveness simplify immunization schedule compare high-dose one .</brief_summary>
	<brief_title>Comparative Efficacy Intensified Re-vaccination Scheme Hepatitis B Virus Infection Among Patients Infected With HIV .</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Older 18 year age . Patients infected Human Immunodeficiency Virus ( HIV ) Failed previous vaccination standard dose scheme recombinant hepatitis B vaccine ( 20mcg 0 , 1 6 month ) . Nonresponders consider patient present hepatitis B surface antigen antibody titer low 10UI/mL 4 8 week last dose vaccine . Provision inform consent . Proven Hepatitis B virus infection ( acute chronic ) . Proven hypersensitivity vaccine component .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Vaccine</keyword>
	<keyword>Primary Prevention</keyword>
	<keyword>Immunogenicity</keyword>
</DOC>